Recent work showed that RNF43 is associated with aggressive tumor biology along with BRAF mutation in right sided CRC18, further supporting a distinct pathogenic mechanism and regional preference for Wnt pathway alterations. The gene discussed is BRAF; the disease is neoplasm.